Approval · Notice of Compliance 24143 · 2020
GLYCON: Notice of Compliance 24143
Issued August 31, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24143
- Date
- August 31, 2020
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Updated labelling materials
- Canadian reference product
- GLUCOPHAGE (Sanofi-Aventis Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GLYCON | Not yet assigned | — |
Medicinal ingredients
- METFORMIN HYDROCHLORIDE 500 MG per TAB
- METFORMIN HYDROCHLORIDE 850 MG per TAB